跳到正文
openFDA 已分级药品召回执法报告·精选AI 评分64

FDA 执法报告 D-0788-2026:Fresenius Kabi 因标签混淆召回 Morphine Sulfate 注射液,列为 Class I

FDA drug enforcement D-0788-2026: Fresenius Kabi USA, LLC — Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

AI 导读

FDA 执法报告 D-0788-2026 将 Fresenius Kabi USA 自愿召回的 Morphine Sulfate 注射液(USP,2 mg/mL,1 mL 单剂量预充式注射器)列为 Class I。

推荐理由

记录显示该召回列为 Class I 且仍在进行,可核对标签混淆涉及的产品、批次与分销范围。

正文 · 原文

FDA drug recall enforcement report — D-0788-2026

Report issued: 2026-08-26. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "3 Corporate Dr",

"address_2": "",

"center_classification_date": "20260824",

"city": "Lake Zurich",

"classification": "Class I",

"code_info": "Lot #: 6402820, Exp. Date 12/2028",

"country": "United States",

"distribution_pattern": "Nationwide within the USA.",

"event_id": "99533",

"initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",

"more_code_info": "",

"openfda": {

"application_number": [

"NDA204223"

],

"brand_name": [

"MORPHINE SULFATE"

],

"generic_name": [

"MORPHINE SULFATE"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"Fresenius Kabi, USA LLC"

],

"package_ndc": [

"76045-238-01",

"76045-238-10",

"76045-004-01",

"76045-004-11",

"76045-005-01",

"76045-005-11",

"76045-006-01",

"76045-006-11",

"76045-007-01",

"76045-007-11",

"76045-008-01",

"76045-008-11"

],

"product_ndc": [

"76045-238",

"76045-004",

"76045-005",

"76045-006",

"76045-007",

"76045-008"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"INTRAMUSCULAR",

"INTRAVENOUS"

],

"rxcui": [

"894912",

"894914",

"998212",

"998213",

"1442790",

"2752697"

],

"spl_id": [

"e61f6eb4-cc71-47d3-b2f6-5e689c773779"

],

"spl_set_id": [

"1f53de80-efc8-4930-b3e3-fba0d026af05"

],

"substance_name": [

"MORPHINE SULFATE"

],

"unii": [

"X3P646A2J0"

]

},

"postal_code": "60047-8930",

"product_description": "Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only, Fresenius Kabi, Lake Zurich, IL. Unit of Use NDC Number 76045-004-01; Unit of Sale NDC Number 76045-004-11",

"product_quantity": "625500 syringes",

"product_type": "Drugs",

"reason_for_recall": "Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.",

"recall_initiation_date": "20260804",

"recall_number": "D-0788-2026",

"recalling_firm": "Fresenius Kabi USA, LLC",

"report_date": "20260826",

"state": "IL",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov